Search
Arnica montana
go.drugbank.com/drugs/DB14297InvestigationalArnica montana is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Chicory leaf
go.drugbank.com/drugs/DB14376InvestigationalChicory leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Palm oil
go.drugbank.com/drugs/DB14377InvestigationalPalm oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
APL-9
go.drugbank.com/drugs/DB16460InvestigationalAPL-9 is an investigational drug intended to centrally control the complement cascade at C3, potentially treating various diseases caused by excessive or uncontrolled complement activation. … It shares the same mechanism of action as Apellis’ lead compound, pegcetacoplan (APL-2), but with a lower molecular weight and shorter half-life.
Bleomycin A6
go.drugbank.com/drugs/DB12992InvestigationalBleomycin A6 (also known as boanmycin) has been used in trials studying the treatment of Squamous Cell Lung Cancer. It was developed in China as an antineoplastic antibiotic. … It was shown that besides the antitumor effect, Bleomycin A6 had the ability to alter the tumor microenvironment and could contribute toward lung cancer relapse and metastasis on long-term treatment.
13-deoxydoxorubicin
go.drugbank.com/drugs/DB05706InvestigationalGPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.
(R)-acetoin
go.drugbank.com/drugs/DB04364ExperimentalIt is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.
(S)-acetoin
go.drugbank.com/drugs/DB02788ExperimentalIt is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.
ALGRX 1207
go.drugbank.com/drugs/DB06482ExperimentalALGRX 1207 entered clinical trials for cutaneous neuropathic pain, such as chemotherapy-induced neuropathy, in 2006. It was being developed by Anesiva, but trials have halted.